跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Daptica 10 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Daptica 10
Approved
STANDARD
Daptica 10
Glenmark Pharmaceuticals Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
bb23deb2a7f3d6d2
Company
Glenmark Pharmaceuticals Limited
Type
Standard
Approval Details
Approval Id
bb23deb2a7f3d6d2
Drug Approval Philippines Name
Daptica 10
Product Name
Daptica 10
Registration Number
DRP-12914
Brand Name
Daptica 10
Generic Name
Dapagliflozin
Dosage Form
Film-Coated Tablet
Dosage Strength
10 mg
Manufacturer
Glenmark Pharmaceuticals Limited
Importer
Glenmark Philippines, Inc.
Distributor
Glenmark Philippines, Inc.
Company Detail Path
/organization/glenmark-pharmaceuticals-limited
Issuance Date
28 October 2022
Expiry Date
28 October 2027
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
bb23deb2a7f3d6d2
Type
Standard
Back to Philippines FDA Approvals